{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:37:07Z","timestamp":1793299027220,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0014777","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:00:00Z","timestamp":1793232000000}}],"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-005121, INV-061233"],"award-info":[{"award-number":["INV-005121, INV-061233"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1136014; INV-029415; INV-030014"],"award-info":[{"award-number":["OPP1136014; INV-029415; INV-030014"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Belgian Directorate-general for Development Cooperation and Humanitarian Aid"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Gambiense<\/jats:italic>\n                      human African trypanosomiasis (gHAT) is marked for elimination of transmission (EoT) by 2030. We examined the cost-effectiveness (CE) of EoT in the Democratic Republic of Congo, the country with the highest burden.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In 165 health zones (HZs), we modelled the transmission dynamics, health outcomes, and economic costs of six strategies during 2026\u201340, including cessation activities once reported cases reach zero. Uncertainty in CE was assessed within the net monetary framework, presenting optimal strategies across willingness-to-pay (WTP) values, in costs per disability-adjusted life-year averted. We assessed the optimal strategy for CE and EoT in each health zone separately, but present results by health zone, by coordination, and for the whole country.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Status Quo strategies, CE strategies (WTP\u2009=\u2009$500), and strategies that maximise the probability of EoT by 2030 are predicted to yield EoT by 2030 in 118 HZs, 123 HZs, and 134 HZs respectively, at a cost by 2040 of $67.8M [95% PI: $36.7M\u2013113M], $93.3M [95% PI: $51.6M\u2013153M], $185M [95% PI: $111M\u2013309M]. A more lenient timeline of EoT by 2040 would lead to EoT in 152 HZs at a cost of $158M [95% PI: $91.6-265M], leaving 13 HZs shy of the goal. Costs would have to be front-loaded; in 2026, while\n                      <jats:italic>Status Quo<\/jats:italic>\n                      strategies would cost $8.75M [95% PI: $7.01M\u201311.2M], elimination strategies would cost $27.0 [95% PI: $21.0M\u201335.2M]. Investing in EoT by 2030 is predicted to reduce 68% of gHAT deaths from 7979 [95% PI: 770\u201327,868] with\n                      <jats:italic>Status Quo<\/jats:italic>\n                      strategies to 2576 [95% PI: 255\u20139133].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Current tools could make considerable progress to maximise the probability of EoT by 2030, but novel tools could help in select health zones that are facing a low probability of EoT even with more ambitious strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0014777","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:41:26Z","timestamp":1792690886000},"page":"e0014777","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness of end-game strategies against sleeping sickness across the Democratic Republic of Congo"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0235-6030","authenticated-orcid":true,"given":"Marina","family":"Antillon","sequence":"first","affiliation":[{"name":"Swiss Tropical and Public Health Institute","place":["Basel-Land, Switzerland"],"department":["Department of Epidemiology and Public Health"]},{"name":"University of Basel","place":["Basel-Stadt, Switzerland"]},{"name":"Zeeman Institute, University of Warwick","place":["Coventry, United Kingdom"]},{"name":"Mathematics Institute, University of Warwick","place":["Coventry, United Kingdom"]},{"name":"Warwick Medical School, University of Warwick","place":["Coventry, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-I","family":"Huang","sequence":"additional","affiliation":[{"name":"Zeeman Institute, University of Warwick","place":["Coventry, United Kingdom"]},{"name":"Mathematics Institute, University of Warwick","place":["Coventry, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"Sutherland","sequence":"additional","affiliation":[{"name":"Zeeman Institute, University of Warwick","place":["Coventry, United Kingdom"]},{"name":"Mathematics Institute, University of Warwick","place":["Coventry, United Kingdom"]},{"name":"Warwick Medical School, University of Warwick","place":["Coventry, United Kingdom"]},{"name":"University of Warwick","place":["Coventry, United Kingdom"],"department":["Warwick Centre for Global Health"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald E.","family":"Crump","sequence":"additional","affiliation":[{"name":"Zeeman Institute, University of Warwick","place":["Coventry, United Kingdom"]},{"name":"Mathematics Institute, University of Warwick","place":["Coventry, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Brown","sequence":"additional","affiliation":[{"name":"Zeeman Institute, University of Warwick","place":["Coventry, United Kingdom"]},{"name":"Mathematics Institute, University of Warwick","place":["Coventry, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Bessell","sequence":"additional","affiliation":[{"name":"Independent Consultant","place":["Edinburgh, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily H.","family":"Crowley","sequence":"additional","affiliation":[{"name":"Zeeman Institute, University of Warwick","place":["Coventry, United Kingdom"]},{"name":"Mathematics Institute, University of Warwick","place":["Coventry, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rian","family":"Snijders","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute","place":["Basel-Land, Switzerland"],"department":["Department of Epidemiology and Public Health"]},{"name":"University of Basel","place":["Basel-Stadt, Switzerland"]},{"name":"Institute of Tropical Medicine","place":["Antwerp, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hope","sequence":"additional","affiliation":[{"name":"Liverpool School of Tropical Medicine","place":["Liverpool, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki","family":"Tirados","sequence":"additional","affiliation":[{"name":"Liverpool School of Tropical Medicine","place":["Liverpool, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dunkley","sequence":"additional","affiliation":[{"name":"Liverpool School of Tropical Medicine","place":["Liverpool, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Verl\u00e9","sequence":"additional","affiliation":[{"name":"Institute of Tropical Medicine","place":["Antwerp, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junior","family":"Lebuki","sequence":"additional","affiliation":[{"name":"Programme National de Lutte contre la Trypanosomiase Humaine Africaine","place":["Kinshasa, Democratic Republic of Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chansy","family":"Shampa","sequence":"additional","affiliation":[{"name":"Programme National de Lutte contre la Trypanosomiase Humaine Africaine","place":["Kinshasa, Democratic Republic of Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick Mwamba","family":"Miaka","sequence":"additional","affiliation":[{"name":"Programme National de Lutte contre la Trypanosomiase Humaine Africaine","place":["Kinshasa, Democratic Republic of Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Tediosi","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute","place":["Basel-Land, Switzerland"],"department":["Department of Epidemiology and Public Health"]},{"name":"University of Basel","place":["Basel-Stadt, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kat S.","family":"Rock","sequence":"additional","affiliation":[{"name":"Zeeman Institute, University of Warwick","place":["Coventry, United Kingdom"]},{"name":"Mathematics Institute, University of Warwick","place":["Coventry, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"pntd.0014777.ref001","unstructured":"World Health Organization. Global Health Observatory data repository. 2020. Available from: https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/hat-tb-gambiense"},{"issue":"4","key":"pntd.0014777.ref002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012111","article-title":"The elimination of human African trypanosomiasis: Monitoring progress towards the 2021-2030 WHO road map targets","volume":"18","author":"JR Franco","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0014777.ref003","unstructured":"WHO Expert Committee on human African trypanosomiasis. Control and surveillance of human African trypanosomiasis: report of a WHO expert committee. 2013. Available from: https:\/\/www.who.int\/trypanosomiasis_african\/surveillance\/en\/"},{"key":"pntd.0014777.ref004","volume-title":"Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021\u20132030","author":"World Health Organization","year":"2020"},{"issue":"1","key":"pntd.0014777.ref005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008532","article-title":"Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo","volume":"17","author":"RE Crump","year":"2021","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"pntd.0014777.ref006","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41467-022-29192-w","article-title":"Identifying regions for enhanced control of gambiense sleeping sickness in the Democratic Republic of Congo","volume":"13","author":"C-I Huang","year":"2022","journal-title":"Nat Commun"},{"key":"pntd.0014777.ref007","unstructured":"Liverpool School of Tropical Medicine. Use of tiny targets to control tsetse flies in Gambian HAT foci: standard operating procedures. 2016."},{"issue":"10","key":"pntd.0014777.ref008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008270","article-title":"Impact of tiny targets on Glossina fuscipes quanzensis, the primary vector of human African trypanosomiasis in the Democratic Republic of the Congo","volume":"14","author":"I Tirados","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0014777.ref009","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41467-022-28598-w","article-title":"Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo","volume":"13","author":"M Antillon","year":"2022","journal-title":"Nat Commun"},{"issue":"7","key":"pntd.0014777.ref010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010599","article-title":"Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC","volume":"16","author":"RE Crump","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0014777.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010047","article-title":"The elimination of human African trypanosomiasis: Achievements in relation to WHO road map targets for 2020","volume":"16","author":"JR Franco","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0014777.ref012","unstructured":"American Red Cross. DRC Health Zone and Health Area boundaries. United Nations Office for Coordination of Humanitarian Affairs; 2020. Available from: https:\/\/data.humdata.org\/dataset\/drc-health-data"},{"issue":"15","key":"pntd.0014777.ref013","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1002\/hyp.9740","article-title":"Global river hydrography and network routing: baseline data and new approaches to study the world\u2019s large river systems","volume":"27","author":"B Lehner","year":"2013","journal-title":"Hydrol Process"},{"key":"pntd.0014777.ref014","volume-title":"WHO interim guidelines for the treatment of gambiense human African trypanosomiasis","author":"WHO Department of Control of Neglected Tropical Diseases","year":"2019"},{"key":"pntd.0014777.ref015","author":"World Health Organization","year":"2024"},{"key":"pntd.0014777.ref016","unstructured":"Office for the Coordination of Humanitarian Affairs. Journees Nationales de Vaccination (JNV) activities de vaccination supplementaire, RDC. 2015. Available from: https:\/\/data.humdata.org\/dataset\/rdc-statistiques-des-populations"},{"issue":"5","key":"pntd.0014777.ref017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008261","article-title":"Monitoring the elimination of human African trypanosomiasis at continental and country level: update to 2018","volume":"14","author":"JR Franco","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"pntd.0014777.ref018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003480","article-title":"Accuracy of individual rapid tests for serodiagnosis of gambiense sleeping sickness in West Africa","volume":"9","author":"V Jamonneau","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"pntd.0014777.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008832","article-title":"Cost of a new method of active screening for human African trypanosomiasis in the Democratic Republic of the Congo","volume":"14","author":"R Snijders","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"pntd.0014777.ref020","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3201\/eid2708.202399","article-title":"Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo","volume":"27","author":"R Snijders","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"pntd.0014777.ref021","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3201\/eid1310.060358","article-title":"Cost-effectiveness of algorithms for confirmation test of human African trypanosomiasis","volume":"13","author":"P Lutumba","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"pntd.0014777.ref022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204335","article-title":"Cost-effectiveness of using a rapid diagnostic test to screen for human African trypanosomiasis in the Democratic Republic of the Congo","volume":"13","author":"PR Bessell","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"pntd.0014777.ref023","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.vaccine.2015.10.045","article-title":"The actual and potential costs of meningitis surveillance in the African meningitis belt: Results from Chad and Niger","volume":"34","author":"M Irurzun-Lopez","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"pntd.0014777.ref024","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actatropica.2006.12.002","article-title":"Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children","volume":"101","author":"G Eperon","year":"2006","journal-title":"Acta Trop"},{"issue":"11","key":"pntd.0014777.ref025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001920","article-title":"In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness","volume":"6","author":"C Schmid","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"pntd.0014777.ref026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pctr.0010039","article-title":"Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda","volume":"1","author":"G Priotto","year":"2006","journal-title":"PLoS Clin Trials"},{"issue":"11","key":"pntd.0014777.ref027","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/522982","article-title":"Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo","volume":"45","author":"G Priotto","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pntd.0014777.ref028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000064","article-title":"Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series","volume":"1","author":"F Checchi","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"issue":"9683","key":"pntd.0014777.ref029","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"G Priotto","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"pntd.0014777.ref030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/649917","article-title":"How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness","volume":"201","author":"D Mumba Ngoyi","year":"2010","journal-title":"J Infect Dis"},{"issue":"2","key":"pntd.0014777.ref031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004362","article-title":"Efficacy, Safety, and Dose of Pafuramidine, a New Oral Drug for Treatment of First Stage Sleeping Sickness, in a Phase 2a Clinical Study and Phase 2b Randomized Clinical Studies","volume":"10","author":"C Burri","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"pntd.0014777.ref032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004363","article-title":"Efficacy and Safety of Pafuramidine versus Pentamidine Maleate for Treatment of First Stage Sleeping Sickness in a Randomized, Comparator-Controlled, International Phase 3 Clinical Trial","volume":"10","author":"G Pohlig","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0014777.ref033","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13071-018-2634-x","article-title":"A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda","volume":"11","author":"F Kansiime","year":"2018","journal-title":"Parasit Vectors"},{"issue":"10116","key":"pntd.0014777.ref034","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0140-6736(17)32758-7","article-title":"Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial","volume":"391","author":"VKBK Mesu","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"pntd.0014777.ref035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/cid\/cis886","article-title":"Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: M\u00e9decins Sans Fronti\u00e8res experience in the Democratic Republic of the Congo","volume":"56","author":"E Alirol","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"10","key":"pntd.0014777.ref036","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2471\/BLT.05.028399","article-title":"Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo","volume":"84","author":"M Balasegaram","year":"2006","journal-title":"Bull World Health Organ"},{"key":"pntd.0014777.ref037","first-page":"68","article-title":"Effectiveness of short vs. long treatment schedules with pentamidine in first-stage HAT: a large field cohort study","volume":"16","author":"S Bastide","year":"2011","journal-title":"Trop Med Int Health"},{"key":"pntd.0014777.ref038","volume-title":"Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis","author":"World Health Organization","year":"2003"},{"key":"pntd.0014777.ref039","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12962-017-0083-6","article-title":"Disease control programme support costs: an update of WHO-CHOICE methodology, price databases and quantity assumptions","volume":"15","author":"MY Bertram","year":"2017","journal-title":"Cost Eff Resour Alloc"},{"key":"pntd.0014777.ref040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12962-018-0095-x","article-title":"Econometric estimation of WHO-CHOICE country-specific costs for inpatient and outpatient health service delivery","volume":"16","author":"K Stenberg","year":"2018","journal-title":"Cost Eff Resour Alloc"},{"issue":"1","key":"pntd.0014777.ref041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-018-3211-x","article-title":"Assessing out-of-pocket expenditures for primary health care: how responsive is the Democratic Republic of Congo health system to providing financial risk protection?","volume":"18","author":"S Laokri","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"pntd.0014777.ref042","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.actatropica.2015.06.003","article-title":"Human African trypanosomiasis prevention, treatment and control costs: a systematic review","volume":"150","author":"J Keating","year":"2015","journal-title":"Acta Trop"},{"issue":"2","key":"pntd.0014777.ref043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001007","article-title":"The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward","volume":"5","author":"PP Simarro","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"pntd.0014777.ref044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011959","article-title":"The cost of sleeping sickness vector control in Yasa Bonga, a health district in the Democratic Republic of the Congo","volume":"18","author":"R Snijders","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"pntd.0014777.ref045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001950","article-title":"Human African Trypanosomiasis in the Democratic Republic of the Congo: A Looming Emergency?","volume":"6","author":"E Hasker","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0014777.ref046","unstructured":"United Nations Population Division. World Population Prospects 2019. 2019. Available from: https:\/\/population.un.org\/wpp\/"},{"issue":"10159","key":"pntd.0014777.ref047","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0140-6736(18)32335-3","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 DALYs and HALE Collaborators","year":"2018","journal-title":"Lancet"},{"key":"pntd.0014777.ref048","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13104-015-1244-3","article-title":"Updated estimate of the duration of the meningo-encephalitic stage in gambiense human African trypanosomiasis","volume":"8","author":"F Checchi","year":"2015","journal-title":"BMC Res Notes"},{"issue":"5","key":"pntd.0014777.ref049","first-page":"479","article-title":"Handling uncertainty in combined endpoints","volume":"17","author":"AH Briggs","year":"2000","journal-title":"Pharmacoecnomics"},{"issue":"2","key":"pntd.0014777.ref050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: alternative approaches","volume":"93","author":"E Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"issue":"8","key":"pntd.0014777.ref051","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jval.2016.02.017","article-title":"Country-level cost-effectiveness thresholds: initial estimates and the need for further research","volume":"19","author":"B Woods","year":"2016","journal-title":"Value Health"},{"issue":"1","key":"pntd.0014777.ref052","article-title":"Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo","volume":"11","author":"KS Rock","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"pntd.0014777.ref053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008696","article-title":"Feasibility of community-based control of tsetse: A pilot project using Tiny Targets in the Democratic Republic of Congo","volume":"14","author":"C Vander Kelen","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0014777.ref054","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-006879","article-title":"\u201cWhere are the dead flies!\u201d: perceptions of local communities towards the deployment of Tiny Targets to control tsetse in the Democratic Republic of the Congo","volume":"7","author":"C Vander Kelen","year":"2022","journal-title":"BMJ Glob Health"},{"issue":"6","key":"pntd.0014777.ref055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001325","article-title":"Community empowerment through participation in a tsetse control project in the Democratic Republic of Congo","volume":"3","author":"C Vander Kelen","year":"2023","journal-title":"PLOS Glob Public Health"},{"issue":"4","key":"pntd.0014777.ref056","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1473-3099(22)00660-0","article-title":"Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2\/3 trial","volume":"23","author":"VK Betu Kumeso","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"pntd.0014777.ref057","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1264","article-title":"Trypanosoma brucei gambiense-iELISA: A Promising New Test for the Post-Elimination Monitoring of Human African Trypanosomiasis","volume":"73","author":"M Geerts","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"pntd.0014777.ref058","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2471\/BLT.23.290106","article-title":"WHO target product profiles: four diagnostic tests needed in the effort to eliminate African trypanosomiasis","volume":"101","author":"G Priotto","year":"2023","journal-title":"Bull World Health Organ"},{"key":"pntd.0014777.ref059","doi-asserted-by":"crossref","unstructured":"Davis CN, Crump RE, Sutherland SA, Spencer SEF, Corbella A, Chansy S. Comparison of stochastic and deterministic models for gambiense sleeping sickness at different spatial scales: A health area analysis in the DRC. MedRxiv. 2023.","DOI":"10.1101\/2023.08.17.23294225"},{"key":"pntd.0014777.ref060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-072X-13-4","article-title":"Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis","volume":"13","author":"PP Simarro","year":"2014","journal-title":"Int J Health Geogr"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0014777","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:00:00Z","timestamp":1793232000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:09:27Z","timestamp":1793297367000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014777"}},"subtitle":[],"editor":[{"given":"Robert","family":"Opiro","sequence":"first","affiliation":[{"name":"Gulu University Faculty of Science","place":["UGANDA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":60,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0014777","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]}}}